Mexico - Latin America Metagenomics Market Size & Outlook
The metagenomics market in Mexico - Latin America is expected to reach a projected revenue of US$ 101.5 million by 2030. A compound annual growth rate of 13.8% is expected of Mexico - Latin America metagenomics market from 2024 to 2030.
In terms of revenue, Mexico accounted for 2.0% of the global metagenomics market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Brazil metagenomics market is projected to lead the regional market in terms of revenue in 2030.
Brazil is the fastest growing regional market in Latin America and is projected to reach USD 191.5 million by 2030.
High incidence of chronic & infectious diseases and growing medical tourism in the country, due to its cost-effective healthcare services, are significantly boosting the demand for metagenomics tools for clinical applications.
Furthermore, Mexico is the second-largest pharmaceutical market in Latin America after Brazil. It has emerged as one of the potential countries for biopharmaceutical products, owing to the presence of skilled scientists, low manufacturing costs, and advanced legal framework.
Moreover, high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology sector. In addition, the Mexican government has prioritized growth and innovation in the biotechnology sector.
Mexico - Latin America Metagenomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 61.46% in 2023.
Horizon Databook has segmented the Mexico - Latin America metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
High incidence of chronic & infectious diseases and growing medical tourism in the country, due to its cost-effective healthcare services, are significantly boosting the demand for metagenomics tools for clinical applications.
Furthermore, Mexico is the second-largest pharmaceutical market in Latin America after Brazil. It has emerged as one of the potential countries for biopharmaceutical products, owing to the presence of skilled scientists, low manufacturing costs, and advanced legal framework.
Moreover, high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology sector. In addition, the Mexican government has prioritized growth and innovation in the biotechnology sector.
Mexico - Latin America Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
Others
Clinical Diagnostics
Drug Discovery
Biotechnology
Environmental
Food & nutrition
Mexico - Latin America Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
Whole Genome Sequencing
Shotgun Sequencing
Others
16S Sequencing
Mexico - Latin America Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
Sequencing & Data Analytics Services
Kits & Reagents
Software
Mexico - Latin America Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
Pre-sequencing
Sequencing
Data Analysis
Reasons to subscribe to Metagenomics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Metagenomics Market Outlook databook
Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - Latin America Metagenomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - Latin America Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Mexico - Latin America Metagenomics Market, 2018-2030 (US$M)